Stockreport

Akari Announces Coversin Data to be Presented at 2018 Complement-Based Drug Development Summit

Akari Therapeutics Plc - American Depositary Shares  (AKTX) 
US:NASDAQ Investor Relations: investor.akaritx.com/investor-relations
PDF Highlights potential role of both complement and leukotriene pathways in a therapeutic mouse model of rheumatoid arthritis (RA) NEW YORK and LONDON, Nov. 15, 2018 (GL [Read more]